Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Berk

Showing results (321-330 of 1,136) with videos related to

Pageof 114
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 16, 2014
Towards stage specific treatments: effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophreniaMarta Rapado-Castro, Michael Berk, Kamalesh Venugopal, et al.
Bipolar Disorders|June 22, 2018
Incidence and characteristics of the nocebo response from meta-analyses of the placebo arms of clinical trials of olanzapine for bipolar disorderSeetal Dodd, Adam J Walker, Alan J M Brnabic, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 3, 2026
Sexual dysfunction in bipolar disorder: A systematic reviewYolanda Cañada, Pablo Navalon, Robson Zazula, et al.
Pharmacological Reports : PR|November 10, 2019
An immune gate of depression - Early neuroimmune development in the formation of the underlying depressive disorderMałgorzata Kowalczyk, Janusz Szemraj, Katarzyna Bliźniewska, et al.
The International Journal of Neuropsychopharmacology|February 9, 2020
Induced Ketosis as a Treatment for Neuroprogressive Disorders: Food for Thought?Gerwyn Morris, Basant K Puri, Andre Carvalho, et al.
Journal of Affective Disorders|April 28, 2012
The use of hormonal contraceptive agents and mood disorders in womenGjertrud Svendal, Michael Berk, Julie A Pasco, et al.
Neuroscience and Biobehavioral Reviews|July 6, 2016
Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implicationsGiselli Scaini, Gislaine T Rezin, Andre F Carvalho, et al.
The Australian and New Zealand Journal of Psychiatry|May 15, 2009
Reliability of the Mood Disorder Questionnaire: comparison with the Structured Clinical Interview for the DSM-IV-TR in a population sampleSeetal Dodd, Lana J Williams, Felice N Jacka, et al.
Journal of Affective Disorders|August 1, 2014
Application of the Gradient Boosted method in randomised clinical trials: Participant variables that contribute to depression treatment efficacy of duloxetine, SSRIs or placeboSeetal Dodd, Michael Berk, Katarina Kelin, et al.
BMC Psychiatry|July 26, 2013
Gastro oesophageal reflux disease (GORD)-related symptoms and its association with mood and anxiety disorders and psychological symptomology: a population-based study in womenLivia Sanna, Amanda L Stuart, Michael Berk, et al.
Pageof 114

Showing results (321-330 of 1,136) with videos related to

Sort By:
Pageof 114
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 16, 2014
Towards stage specific treatments: effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophreniaMarta Rapado-Castro, Michael Berk, Kamalesh Venugopal, et al.
Bipolar Disorders|June 22, 2018
Incidence and characteristics of the nocebo response from meta-analyses of the placebo arms of clinical trials of olanzapine for bipolar disorderSeetal Dodd, Adam J Walker, Alan J M Brnabic, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 3, 2026
Sexual dysfunction in bipolar disorder: A systematic reviewYolanda Cañada, Pablo Navalon, Robson Zazula, et al.
Pharmacological Reports : PR|November 10, 2019
An immune gate of depression - Early neuroimmune development in the formation of the underlying depressive disorderMałgorzata Kowalczyk, Janusz Szemraj, Katarzyna Bliźniewska, et al.
The International Journal of Neuropsychopharmacology|February 9, 2020
Induced Ketosis as a Treatment for Neuroprogressive Disorders: Food for Thought?Gerwyn Morris, Basant K Puri, Andre Carvalho, et al.
Journal of Affective Disorders|April 28, 2012
The use of hormonal contraceptive agents and mood disorders in womenGjertrud Svendal, Michael Berk, Julie A Pasco, et al.
Neuroscience and Biobehavioral Reviews|July 6, 2016
Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implicationsGiselli Scaini, Gislaine T Rezin, Andre F Carvalho, et al.
The Australian and New Zealand Journal of Psychiatry|May 15, 2009
Reliability of the Mood Disorder Questionnaire: comparison with the Structured Clinical Interview for the DSM-IV-TR in a population sampleSeetal Dodd, Lana J Williams, Felice N Jacka, et al.
Journal of Affective Disorders|August 1, 2014
Application of the Gradient Boosted method in randomised clinical trials: Participant variables that contribute to depression treatment efficacy of duloxetine, SSRIs or placeboSeetal Dodd, Michael Berk, Katarina Kelin, et al.
BMC Psychiatry|July 26, 2013
Gastro oesophageal reflux disease (GORD)-related symptoms and its association with mood and anxiety disorders and psychological symptomology: a population-based study in womenLivia Sanna, Amanda L Stuart, Michael Berk, et al.
Pageof 114